If your asthma isn’t well controlled despite using a daily corticosteroid inhaler, a clinical research study may be worth exploring. A study testing an investigational oral medication for moderate to severe asthma is now enrolling adults aged 18 and older.
Takes less than 30 seconds · No personal information required
Asthma is a chronic condition that causes the airways to become inflamed and narrow, making it difficult to breathe. Symptoms include wheezing, shortness of breath, chest tightness, and coughing — especially at night or during exercise.
For many people, a daily corticosteroid inhaler keeps symptoms under control. But for those with moderate to severe asthma, standard treatment may not be enough. Breakthrough symptoms, frequent flare-ups, and limitations on daily activities can continue despite using prescribed medications.
Clinical research studies are one way that new treatment approaches are evaluated. This study is exploring whether an investigational oral medication, taken alongside existing asthma treatments, may help people whose asthma is not well controlled.
This study is testing an investigational oral medication for asthma that is not well controlled despite treatment with inhaled corticosteroids. Participants will continue their usual asthma medications and also take two daily doses of either the study medication or a placebo for 6 months (24 weeks).
Additional procedures include physical exams, vital signs, blood and urine testing, lung function testing, electrocardiograms (ECGs), and asthma and health questionnaires.
Total participation will last approximately 8 months (32 weeks) and would include 9 office visits and 1 phone call with the study staff. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic.
Complete a brief screening about your asthma diagnosis and current treatment to see if you may be a match.
If you match a study near you, a trial coordinator will reach out to discuss the next steps.
The study doctor will confirm your eligibility during one or more in-person screening visits and walk you through what participation involves.
No. Study-related visits, procedures, and medication are provided at no cost. Compensation for your time and travel may also be provided.
A clinical research study is a carefully designed program that evaluates new or existing treatments under medical supervision. Every study must be reviewed and approved by an independent ethics committee before it begins. Participation is always voluntary.
No. Participants will continue their usual asthma medications throughout the study. The investigational oral medication is taken in addition to your current treatment.
You’ll answer a few brief questions about your asthma diagnosis and treatment. If you appear to be a match, a trial coordinator will contact you to discuss the study in more detail and schedule a screening visit.
Total participation is approximately 8 months (32 weeks), which includes 9 office visits and 1 phone call with the study staff. The treatment period itself lasts 6 months (24 weeks).
Yes. Participation in any clinical research study is completely voluntary. You may withdraw at any time, for any reason, without it affecting your regular medical care.
Clinical research studies are an essential part of bringing new medical treatments to patients. Here are a few things to know:
Check your eligibility in just a few minutes. There’s no obligation and no cost to see if you may qualify.
A clinical research study for asthma is now enrolling. Check if you may qualify.
Check If You May Qualify